A leading Colorado prostate cancer expert says after a decade and a half of near stagnation, four new drugs - Denosumab, Alpharadin, Prostvac, Abiraterone Acetate - could help make advanced prostate cancer a chronic illness instead of a terminal disease.
The drugs have different and innovative methods of action. One is a bone protective agent; another’s a more effective hormone agent; another is radiotherapy; and the final one is the first drug tested for cancer immunotherapy. It’s not just chemotherapy, added the investigator at the University of Colorado Cancer Center. Now with these news drugs we’re tacking on even more time. The light at the end of the tunnel is the hope that we’ll turn this into a chronic disease and now we might have the tools that in some combination will do it.
No User Responded In This Post
Before Leave Your Comments Here Click Below On Our Sponsors...